News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Seattle biotech CEO keeps a watchful eye on the market for potential IPO
Kineta Inc. CEO, Shawn Iadonato recently spoke to PSBJ about laying the groundwork for an IPO. Iadonato told PSBJ’s Megan Campbell, “We’re really watching the capital markets closely.
Seattle Genetics, Astellas’ bladder cancer med Padcev blows early expectations out of the water
Seattle-based Seattle Genetics and Astellas’ new bladder cancer treatment, Pandcev exceeded sales expectations in Q1. In a note to clients, J.P. Morgan analyst, Cory Kasimov
General Motors and Ventec to deliver first batch of ventilators ahead of schedule
General Motors and Bothell-based Ventec Life Systems are participating in a joint effort to build ventilators and add to the nation’s stockpile used to care
Adaptive Biotech’s deal with Amgen influenced by belief that COVID-19 may return seasonally, like flu
Amgen plans to use Adaptive Biotech’s proprietary technology platform to develop therapies to treat the coronavirus, especially for those working on the frontlines treating patients.
Seattle Institute’s Coronavirus Treatment Study Gets Quick FDA Approval
A potentially groundbreaking novel coronavirus treatment being explored by Seattle’s Infectious Disease Research Institute has received FDA approval to start human trials. Dr. Corey Casper, the Institute’s
Microsoft and Adaptive Biotechnologies are studying how the human immune system reacts to the coronavirus
Microsoft and Adaptive Biotechnologies are spearheading an effort to understand how the human immune system responds to the coronavirus, and why some people become so